Anika Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Anika Therapeutics

06/08/2021 19:51

* Anika Therapeutics Inc  ANIK.OQ  reported quarterly adjusted
earnings of 45 cents​​ per share for the quarter ended in June.
The mean expectation of three analysts for the quarter was for a
loss of 15 cents per share.
* Revenue rose 24.3% to $38.15 million from a year ago; 
analysts expected $34.51 million. 
* Anika Therapeutics Inc's reported EPS for the quarter was 45
cents​.
* The mean earnings estimate of analysts had fallen by
about 125.6% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Anika Therapeutics Inc shares had fallen by 5.1% this
quarter and lost 9.2% so far this year.
* The company reported quarterly net income of $6.53 million.
* Wall Street's median 12-month price target for Anika
Therapeutics Inc is $46.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 6 at 06:50 p.m.  ​All
figures in US dollars unless otherwise stated